TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pharmadule Morimatsu AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
353,594
|
841,322
|
484,728 |
| Financial expenses |
25,912
|
26,069
|
148,807 |
| Earnings before taxes |
10,633
|
29,984
|
16,497 |
| EBITDA |
14,637
|
13,858
|
-14,368 |
| Total assets |
620,300
|
396,189
|
307,578 |
| Current assets |
618,220
|
394,110
|
293,346 |
| Current liabilities |
550,940
|
301,218
|
237,800 |
| Equity capital |
65,950
|
91,561
|
67,908 |
| - share capital |
2,000
|
2,000
|
2,000 |
| Employees (average) |
16
|
14
|
14 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
10.6%
|
23.1%
|
22.1% |
| Turnover per employee |
22,100
|
60,094
|
34,623 |
| Profit as a percentage of turnover |
3.0%
|
3.6%
|
3.4% |
| Return on assets (ROA) |
5.9%
|
14.1%
|
53.7% |
| Current ratio |
112.2%
|
130.8%
|
123.4% |
| Return on equity (ROE) |
16.1%
|
32.7%
|
24.3% |
| Change turnover |
-487,728
|
356,594
|
269,851 |
| Change turnover % |
-58%
|
74%
|
126% |
| Chg. No. of employees |
2
|
0
|
0 |
| Chg. No. of employees % |
14%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.